Archives of Clinical Infectious Diseases

Published by: Kowsar

Eradication of Polio in the World; Iran is at Risk for Reemerging of Polio: A Review of the Literature

Seyed Mansour Razavi 1 , Masoud Mardani 2 and Payman Salamati 3 , *
Authors Information
1 Department of Community Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e36867
  • Published Online: August 2, 2016
  • Article Type: Review Article
  • Received: March 3, 2016
  • Accepted: July 26, 2016
  • DOI: 10.5812/archcid.36867

To Cite: Razavi S M, Mardani M, Salamati P. Eradication of Polio in the World; Iran is at Risk for Reemerging of Polio: A Review of the Literature, Arch Clin Infect Dis. 2016 ; 11(4):e36867. doi: 10.5812/archcid.36867.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
Footnotes
References
  • 1. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-Derived Polioviruses And The Endgame Strategy For Global Polio Eradication. Annu. Rev. Microbiol. 2005; 59: 587-635
  • 2. Sutter WR, Stephen L. Cochi Poliomyelitis. Maxy Rosenau Last Public Health and Preventive Medicine. 2008;
  • 3. Emad MR, Pakmanesh K, Sedaghat P. Evaluation of sympathetic skin response in old-polio patients. Iran Red Crescent Med J. 2011; 13(11): 829-31[PubMed]
  • 4. Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM, Centers for Disease C, et al. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(23): 640-6[PubMed]
  • 5. Moussavi T, Sadrizadeh B, Zahraei M, Nategh R, Nadim A. Polio eradication in Iran. Arch Iran Med. 2012; 15(2): 107-9[PubMed]
  • 6. Ministry of Health and Medical Education DOH. Children immunization program in the Islamic Republic of Iran. 2014;
  • 7. Oral polio vaccine (OPV). . Global Polio eradication initiative. 2010;
  • 8. Immunization Systems Management Group of the Global Polio Eradication I. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016. MMWR Morb Mortal Wkly Rep. 2015; 64(25): 699-702[PubMed]
  • 9. World Health Organization (WHO). . Weekly epidemiological record. 2015; 90: 337-48
  • 10. Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014; 210 Suppl 1: 283-93[DOI][PubMed]
  • 11. Mir F, Quadri F, Mach O, Ahmed I, Bhatti Z, Khan A, et al. Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial. Lancet Infect Dis. 2015; 15(8): 889-97[DOI][PubMed]
  • 12. Izadi S, Shahmahmoodi S, Zahraei SM, Dorostkar F, Majdzadeh R. Risk of polio reintroduction to border regions of Islamic Republic of Iran: seroprevalence study of children with at least 5 doses of oral polio vaccine. East Mediterr Health J. 2014; 20(5): 287-94[PubMed]
  • 13. Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, et al. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet. 1993; 341(8860): 1545-50[PubMed]
  • 14. Habib MA, Soofi S, Sheraz A, Bhatti ZS, Okayasu H, Zaidi SZ, et al. Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial. Vaccine. 2015; 33(6): 819-25[DOI][PubMed]
  • 15. World Health Organization. . WHO vaccine-preventable diseases: monitoring system 2014 global summary. 2015;
  • 16. Li L, Ivanova O, Driss N, Tiongco-Recto M, da Silva R, Shahmahmoodi S, et al. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series. J Infect Dis. 2014; 210 Suppl 1: 368-72[DOI][PubMed]
  • 17. Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, et al. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Invest. 2014; 43(3): 292-8[DOI][PubMed]
  • 18. Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Polio endgame: the global introduction of inactivated polio vaccine. Expert Rev Vaccines. 2015; 14(5): 749-62[DOI][PubMed]
  • 19. Moradi-Lakeh M, Esteghamati A. National Immunization Program in Iran: whys and why nots. Hum Vaccin Immunother. 2013; 9(1): 112-4[DOI][PubMed]
  • 20. Global Polio eradication initiative. 2011;
  • 21. Zahraei SM, Marandi A, Sadrizadeh B, Gouya MM, Rezaei P, Vazirian P, et al. Role of National Immunization Technical Advisory Group on improvement of immunization programmes in the Islamic Republic of Iran. Vaccine. 2010; 28 Suppl 1: 35-8[DOI][PubMed]
  • 22. Naeini AE, Ghazavi M, Moghim S, Sabaghi A, Fadaei R. Acute flaccid paralysis surveillance: A 6 years study, Isfahan, Iran. Adv Biomed Res. 2015; 4: 99[DOI][PubMed]
  • 23. World Health Organization. . Causes of Acute Flaccid Paralysis (AFP) Worldwide. 2013;
  • 24. Soltani J, Esmailnasab N, Roshani D, Karimi M, Amjadi M. Acute flaccid paralysis and its differential diagnosis in in kurdistan province, Western iran; an 11-year surveillance. Iran J Pediatr. 2014; 24(2): 131-9[PubMed]
  • 25. Poorolajal J, Ghasemi S, Farahani LN, Hosseini AS, Bathaei SJ, Zahiri A. Evaluation of acute flaccid paralysis in hamadan, iran from 2002 to 2009. Epidemiol Health. 2011; 33: 2011011[DOI][PubMed]
  • 26. Salehiomran MR, Naserkhaki S, Hajiahmadi M. Acute generalized weakness in patients referred to Amirkola Children's Hospital from 2005 to 2010. Caspian J Intern Med. 2012; 3(2): 425-7[PubMed]
  • 27. Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008; 137(1): 168-72[DOI][PubMed]
  • 28. Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Sedaghat M, et al. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates. Turk J Gastroenterol. 2014; 25 Suppl 1: 26-31[DOI][PubMed]
  • 29. Rahimi P, Tabatabaie H, Gouya MM, Zahraie M, Mahmudi M, Ziaie A, et al. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran. J Clin Virol. 2007; 39(4): 304-7[DOI][PubMed]
  • 30. Parvaneh N, Shahmahmoudi S, Tabatabai H, Zahraei M, Mousavi T, Esteghamati AR, et al. Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol. 2007; 39(2): 145-8[DOI][PubMed]
  • 31. Shahmahmoodi S, Mamishi S, Aghamohammadi A, Aghazadeh N, Tabatabaie H, Gooya MM, et al. Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerg Infect Dis. 2010; 16(7): 1133-6[DOI][PubMed]
  • 32. Hatami H, Razavi SM, Eftekhar Ardabili H, Majlesi F. Public health comprehensive book. 2013; 2: 1091
  • 33. Paul Y. Role of genetic factors in polio eradication: new challenge for policy makers. Vaccine. 2007; 25(50): 8365-71[DOI][PubMed]
  • 34. Christenson E, Bain R, Wright J, Aondoakaa S, Hossain R, Bartram J. Examining the influence of urban definition when assessing relative safety of drinking-water in Nigeria. Sci Total Environ. 2014; 490: 301-12[DOI][PubMed]
  • 35. List of countries by literacy rate.
  • 36. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004; 78(24): 13512-21[DOI][PubMed]
  • 37. Delpeyroux F, Colbere-Garapin F, Razafindratsimandresy R, Sadeuh-Mba S, Joffret ML, Rousset D, et al. [Eradication of poliomyelitis and emergence of pathogenic vaccine-derived polioviruses: from Madagascar to Cameroon]. Med Sci (Paris). 2013; 29(11): 1034-41[DOI][PubMed]
  • 38. Gadget A. List of Tropical Countries.
  • 39. The Guardian. . Access to clean water. The Guardian.
  • 40. Helmand River i Geography. . Encyclopedia Iranica.
  • 41. Kapp C. Surge in polio spreads alarm in northern Nigeria. Rumours about vaccine safety in Muslim-run states threaten WHO's eradication programme. Lancet. 2003; 362(9396): 1631-2[PubMed]
  • 42. Ahmad K. Pakistan struggles to eradicate polio. Lancet Infect Dis. 2007; 7(4): 247[PubMed]
  • 43. Centers for Disease Control Prevention . Resurgence of wild poliovirus type 1 transmission and consequences of importation--21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep. 2006; 55(6): 145-50[PubMed]
  • 44. Jahan News . The latest statistics of the number of Afghan refugees in Iran. 2015;
  • 45. Asaei SE. Iran's Excellent Primary Health Care System.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments